News of Note—J&J launches neurovascular business; Olympus to pay $6.6M over superbug outbreak

news of note

> Johnson & Johnson unveiled a new neurovascular business, dubbed Cerenovus, which includes products that the conglomerate's Codman Neuro unit picked up in its acquisitions of Pulsar Vascular and stroke care company Neuravi. Release

> A jury ordered endoscope maker Olympus to fork over $6.6 million in damages to a Seattle hospital. The verdict concludes an eight-week trial surrounding the company's endoscopes and drug-resistant infections. MedCityNews story | Read more

> Roxwood Medical has struck a deal with Abbott to distribute its cardiovascular catheters in the U.S. Release


Overcoming Risk in Oncology Drug Development

Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Download this whitepaper for tips on finding the fast track. Premier Research. Built for Biotech.

Suggested Articles

The FDA broadened its approval of Medtronic’s transcatheter aortic valve replacement to include patients at a low risk of surgical complications.

The FDA approved the first spinal tether to correct the most common form of scoliosis—a ropelike implant that pulls the vertebrae into shape.

Agilent launched a new analyzer for research that observes cell behavior in real time while also collecting biosensor information.